Impact of per-cycle changes in spatial and temporal pattern of dose and biokinetics in neuroblastoma patients receiving 177Lu-DOTATATE
<p>Recently, there has been a growth in using post-treatment dosimetry after the first treatment cycle to plan the prescription for subsequent administrations to achieve an acceptable safe dose to kidneys and therapeutic dose to tumour. This level of personalisation recognises inter-patient va...
| Autore principale: | |
|---|---|
| Altri autori: | |
| Natura: | Tesi |
| Lingua: | English |
| Pubblicazione: |
2019
|
| Soggetti: |